Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.10, read 2026-10-24
Ethical does not pass the values gate
Price86.54 USD
Fair value100.23
Ethical score70.0/100
Our investment reviews on this name
2026-10-02Read Accumulation75.89+14.0% to today ✓Markdown gives way to Accumulation
2026-08-28Read Markdown78.51+10.2% to today Markup gives way to Markdown after a 10% slide in 2 days
2026-08-26Read Markup87.58-1.2% to today Accumulation gives way to Markup first Markup read since July
2026-08-09Read Accumulation87.58-1.2% to today Markup gives way to Accumulation after a 7% rise in 5 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
PVH Corp. holds its Accumulation at $86.54. The statistical read favours the sellers, held for 70 days.
As held on the ledger · 2026-10-26
Phase
Accumulation
Quantitative state
The statistical read favours the sellers, held for 70 days
Price at the screen
$86.54
Valuation
N/A trailing · 6.93 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.76
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
36.80%
Below 33%
Interest-bearing debt is 36.8% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
14.52%
Below 49%
Money owed to the company is 14.5% of assets, under the 49% limit.
Pass
Revenue purity
0.17%
Below 5%
Only 0.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
PVH's business is in a permissible area, but its interest-bearing debt is about 37% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when PVH's ethical verdict changes
Today PVH does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-26 screen. The gold marker is the market price at the same screen. A 15.8% margin of safety to the base estimate.
Third-party analyst targets: 11 covering, consensus Buy. The average target sits +2% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-26 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Apparel brands hit the same old cycle trap
Walk into any high street store and the racks tell the same story every few years. PVH owns Tommy Hilfiger and Calvin Klein yet still only grows revenue at 2 percent with profit margins stuck at 2 percent and return on equity at just 3 percent. A forward multiple of 6.3 times looks tempting until you remember this is a cyclical business whose earnings peak right before consumer spending turns.
The ethical screen clears without issue, and the numbers show a company that is neither broken nor particularly well placed. Low growth and thin returns leave little room for error when fashion tastes shift or cotton prices spike. The market has already priced in modest expectations, which is why the opportunity rating stays at none.
Risk sits in the usual places for apparel: sudden changes in consumer habits, heavy competition from faster brands, and the simple fact that low multiples on weak returns often signal a value trap rather than a bargain. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
PVH trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-28Accumulation$86.54+6.1%Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 6.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (12 analysts) rates it buy, with a mean price target of $100.
2026-10-21Accumulation$81.56-0.1%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (12 analysts) rates it buy, with a mean price target of $100.
2026-10-14Accumulation$81.64+7.6%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 7.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (12 analysts) rates it buy, with a mean price target of $100.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (12 analysts) rates it buy, with a mean price target of $100.
2026-09-02Markdown$78.51+0.0%Entry 12
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (12 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-09-01Markdown$78.51+0.0%Entry 11
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (12 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-31Markdown$78.51+0.0%Entry 10
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (12 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-30Markdown$78.51+0.0%Entry 9
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (12 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-29Markdown$78.51+0.0%Entry 8
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (12 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-28Markdown · changed$78.51+0.0%Entry 7
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (12 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.